HOME >> BIOLOGY >> NEWS
Scientists, physicians discuss latest discoveries for stopping cancer before it starts

research the quest to identify drugs and other substances that will ward off the onset of cancer, hinder its progress, reverse its course or diminish the chances of its recurrence is augmenting the search for a cure.

"AACR launched the annual cancer prevention meetings last year, to facilitate the exchange of research results from laboratories and clinical trials, foster translational research, and strengthen the vitally important partnership among basic scientists, clinical oncologists, physician-scientists, behavioral scientists, and epidemiologists from academia, government, and industry, as well as cancer survivor groups," said Karen S. H. Antman, M.D., AACR president and Wu Professor of Medicine and Professor of Pharmacology, Division of Oncology, Department of Medicine, Columbia University, New York.

"This second annual, multidisciplinary conference will link the biology of the cancer process with its clinical prevention and reversal in pre-invasive stages," she added.

In addition to dozens of symposia and poster sessions, the conference will include a lecture by Waun Ki Hong, M.D., of The University of Texas M. D. Anderson Cancer Center. Dr. Hong will receive the second annual AACR-Cancer Research and Prevention Foundation (CRPF) Award for Excellence in Cancer Prevention Research at the meeting, and speak to the participants on the subject of cancer chemoprevention at the molecular level.

The conference will open with a keynote address by Robert A. Weinberg, Ph.D.

Dr. Weinberg is Professor of Biology at the Massachusetts Institute of Technology and the Daniel K. Ludwig and American Cancer Society Professor for Cancer Research at MIT's Whitehead Institute, both in Cambridge, Mass. Hamilton Jordan, former White House Chief of Staff, cancer survivor, patient advocate and author will give a special presentation during the opening session as well.

Dr. Weinberg's remarks will examine another aspect of cancer prevention: the
'"/>

Contact: Elizabeth Tait
tait@aacr.org
215-440-9300
American Association for Cancer Research
23-Oct-2003


Page: 1 2 3

Related biology news :

1. Scientists, lawyers discuss decision-making amid uncertainty
2. Scientists, researchers, animal advocates & regulators to discuss alternatives to animal testing
3. Scientists, ships, aircraft to profile Asian pollution and dust
4. Scientists, research advocates honored as Albert B. Sabin Heroes of Science
5. NCAR Scientists, Aircraft, Instruments Head To Indian Ocean For Climate ChangeExperiment; UCAR Directs Operations
6. Scientists, Using Flies, Trace Genetic Links To Cancer
7. Scientists, Philosophers Discuss How To Evaluate Data, Error
8. Fox Chase discovery may help physicians diagnose, treat devastating childhood disease
9. Many physicians misperceive radiation risks to developing fetuses from X-rays and CT scans
10. Whites, African-Americans better rate medical care experiences when seeing same-race physicians
11. UNC, other physicians setting up national registry

Post Your Comments:
(Date:8/29/2014)... nucleus, chromosomal DNA is tightly bound to structural ... chromatin. Until about two decades ago, histones were ... material around which the glamorous DNA strands were ... appreciation for how DNA/histone interactions govern gene expression. ... studying the sequence of the genome from cancer ...
(Date:8/29/2014)... the Tibetan plateau -- the largest topographic anomaly above ... its profound effect on climate and its reflection of ... Bulletin , Katharine Huntington and colleagues employ a cutting-edge ... and fossil snail shells to investigate the uplift history ... Views range widely on the timing of surface uplift ...
(Date:8/28/2014)... of America (ESA) is pleased to announce the selection ... the Society. Honorary Membership acknowledges those who have served ... in the affairs of the Society that has reached ... by the ESA Governing Board and then voted on ... at the Awards Ceremony at Entomology 2014, ESA,s Annual ...
Breaking Biology News(10 mins):'K-to-M' histone mutations: How repressing the repressors may drive tissue-specific cancers 2'K-to-M' histone mutations: How repressing the repressors may drive tissue-specific cancers 3Snails tell of the rise and fall of the Tibetan Plateau 2Snails tell of the rise and fall of the Tibetan Plateau 3Snails tell of the rise and fall of the Tibetan Plateau 4Snails tell of the rise and fall of the Tibetan Plateau 5Snails tell of the rise and fall of the Tibetan Plateau 6Snails tell of the rise and fall of the Tibetan Plateau 7Fred Baxendale selected as Honorary Member of the Entomological Society of America 2
(Date:8/29/2014)... , Aug. 29, 2014 /PRNewswire/ - iCo Therapeutics ... today reported financial results for the six months ... are expressed in Canadian dollars and presented under ... Quarter 2014 Highlights , Announced top-line ... (VA) primary endpoint for subjects enrolled in the ...
(Date:8/29/2014)... San Antonio, TX (PRWEB) August 29, 2014 ... 9001:2008 and ISO 13485:2003 certified, GAMP® 5 compliant ... been awarded an international Phase II clinical trial ... non-Hodgkin’s lymphoma. , Throughout this trial, Intrinsic Imaging ... but not limited to, protocol and charter development, ...
(Date:8/28/2014)... A new research platform uses a laser ... structures undergoing stress and heating, an approach ... for microelectronics and batteries., This new technique, ... how heating and the surface stress of ... have discussed the merits of surface-stress influence ...
(Date:8/28/2014)... ATLANTA , Aug. 28, 2014   SunTrust ... of three industry veterans to its equity research ... "Our ongoing expansion in equity research demonstrates ... with unique insights to enhance their investment decision ... Equities at STRH.  "We continue to make significant ...
Breaking Biology Technology:iCo Therapeutics Announces Second Quarter 2014 Financial Results 2iCo Therapeutics Announces Second Quarter 2014 Financial Results 3iCo Therapeutics Announces Second Quarter 2014 Financial Results 4Intrinsic Imaging Awarded Phase II Clinical Trial to Assess New Treatment for Non-Hodgkin’s Lymphoma 2New analytical technology reveals 'nanomechanical' surface traits 2New analytical technology reveals 'nanomechanical' surface traits 3SunTrust Robinson Humphrey Expands Equity Research in Healthcare and Energy 2SunTrust Robinson Humphrey Expands Equity Research in Healthcare and Energy 3
Cached News: